Virtual Training Role-Plays to Improve Patient Suicide Outcomes in Primary Care Settings

Suicidal Ideation Clinical Trial

Official title:

Virtual Training Role-Plays to Improve Patient Suicide Outcomes in Primary Care Settings

Clinical Trial Details — Status: Not yet recruiting

Administrative data

• NCT number: NCT03207217
• Other study ID #: R44MH114710-01
• Status: Not yet recruiting
• Phase: N/A
• First received: June 29, 2017
• Last updated: June 29, 2017
• Start date: July 2017
• Est. completion date: March 2020

Study information

• Verified date: June 2017
• Source: SIMmersion, LLC
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

SIMmersion, in collaboration with the Institute for Family Health (IFH) and the Educational Development Center (EDC) propose to develop a web-based training product, Suicide Prevention Role-plays for Interactive Training (SPiRIT), a series of 4 modules to train providers to more effectively manage patients who screen positive for risk of suicide in this Phase I/Phase II fast-track application. If funded, the team will develop the Risk Assessment module in Phase I and utilize a within group pre-post design to evaluate its feasibility. Twenty practicing clinicians will be recruited to utilize the module and complete a pre-post knowledge test. In Phase II, the team will develop Safety Planning, Access to Lethal Means, and Willingness to Accept a Referral modules. The efficacy of the product to positively influence patient outcomes will be tested with a Historically Controlled Trial (HCT) enlisting 65 practicing clinicians across five IFH sites. All providers will be trained and patient outcomes will be tracked for 6 months post training. This data set will be compared to 6 months of historical data for the same provider group. Primary outcomes of this study will measure the participants' ability in obtain improved patient outcomes related to: 1) rate of same-day C-SSRS Screening; 2) rate of suicide being added to the problem list; 3) rate of same-day safety planning; 4) rate of same day C-SSRS Lifeline/Recent Completion; 5) rate of same-day Risk Assessment; 6) rate of acceptance and attendance to within-Institute referrals for post intervention patients who are offered the referral at the first visit; 7) and lower rates of documented suicide attempts. Ultimately, the development and successful testing of this product would provide the US health care system a novel technology to scale up a clinician's confidence and skill to better manage patients who identify as at-risk for suicide. Additionally, if effective, this product will have a direct impact on patient outcomes, a vital component to any training product that attempts to train health care professionals. The utility and scalability of the proposed product will move health care systems toward the goal of zero deaths from suicide consistent with the Zero suicide approach.

Recruitment information / eligibility

• Status: Not yet recruiting
• Enrollment: 91
• Est. completion date: March 2020
• Est. primary completion date: December 2019
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

(1) Hold an active license issued by the State of New York for their profession and be in good standing; (2) actively see patients at an IFH site; and (3) have completed IFH's mandated suicide prevention training.

Exclusion Criteria:

(1) have not completed their IFH Suicide Prevention Training as outlined in the IFH's Suicide Prevention Training Policy; or (2) have uncorrected vision or hearing problems that prevent the person from using the software. Specific to Phase II an additional criteria is (3)participated in the Phase 1 feasibility testing.

Related Conditions & MeSH terms

• Suicidal Ideation
• Suicide

Intervention

Other:
• Web-based training Product
A series of 4 modules to train providers to more effectively manage patients who screen positive for risk of suicide. The modules are: Risk Assessment, Safety Planning, Access to Lethal Means, and Willingness to accept referral.

Locations

Country	Name	City	State
n/a

Sponsors (3)

Lead Sponsor	Collaborator
SIMmersion, LLC	Education Development Center, Inc., The Institute for Family Health

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	C-SSRS Screening	Higher rates of same-day C-SSRS Screening	Assessment will occur after a 6 month period of tracking patient records for each provider
Primary	Suicide addition to Problem List	Higher rates of suicide being added to the problem list	Assessment will occur after a 6 month period of tracking patient records for each provider
Primary	Same-day Safety Planning, if a positive screen	Higher rates of same-day Safety Planning, if a positive screen	Assessment will occur after a 6 month period of tracking patient records for each provider
Primary	C-SSRS Lifeline/Recent Completion	Higher rates of same-day C-SSRS Lifeline/Recent Completion, if a positive screen;	Assessment will occur after a 6 month period of tracking patient records for each provider
Primary	Risk Assessment	Higher rates of same-day Risk Assessment, if a positive screen	Assessment will occur after a 6 month period of tracking patient records for each provider
Primary	Within-Institute referrals	Higher rates of acceptance and attendance to within-Institute referrals for post intervention patients who are offered the referral at the first visit	Assessment will occur after a 6 month period of tracking patient records for each provider
Primary	Documented suicide attempts	Have lower rates of documented suicide attempts	Assessment will occur after a 6 month period of tracking patient records for each provider